The Navigation Guide Systematic Review Methodology: A Rigorous and Transparent Method for Translating Environmental Health Science into Better Health Outcomes

Background: Synthesizing what is known about the environmental drivers of health is instrumental to taking prevention-oriented action. Methods of research synthesis commonly used in environmental health lag behind systematic review methods developed in the clinical sciences over the past 20 years. Objectives: We sought to develop a proof of concept of the “Navigation Guide,” a systematic and transparent method of research synthesis in environmental health. Discussion: The Navigation Guide methodology builds on best practices in research synthesis in evidence-based medicine and environmental health. Key points of departure from current methods of expert-based narrative review prevalent in environmental health include a prespecified protocol, standardized and transparent documentation including expert judgment, a comprehensive search strategy, assessment of “risk of bias,” and separation of the science from values and preferences. Key points of departure from evidence-based medicine include assigning a “moderate” quality rating to human observational studies and combining diverse evidence streams. Conclusions: The Navigation Guide methodology is a systematic and rigorous approach to research synthesis that has been developed to reduce bias and maximize transparency in the evaluation of environmental health information. Although novel aspects of the method will require further development and validation, our findings demonstrated that improved methods of research synthesis under development at the National Toxicology Program and under consideration by the U.S. Environmental Protection Agency are fully achievable. The institutionalization of robust methods of systematic and transparent review would provide a concrete mechanism for linking science to timely action to prevent harm. Citation: Woodruff TJ, Sutton P. 2014. The Navigation Guide systematic review methodology: a rigorous and transparent method for translating environmental health science into better health outcomes. Environ Health Perspect 122:1007–1014; http://dx.doi.org/10.1289/ehp.1307175

[1]  R. Courtney,et al.  The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General, 2014Us Department of Health and Human Services Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for: Critique , 2015 .

[2]  Oar Us Epa,et al.  Benefits and Costs of the Clean Air Act , 2015 .

[3]  L. Giudice,et al.  State of the Science of Endocrine Disrupting Chemicals - 2012 , 2012 .

[4]  A. B. Hill,et al.  "The Environment and Disease: Association or Causation?" (1965), by Austin Bradford Hill , 2017 .

[5]  Ord,et al.  Guidelines for Reproductive Toxicity Risk Assessment , 2014 .

[6]  Ord,et al.  Guidelines for Developmental Toxicity Risk Assessment , 2014 .

[7]  Tracey J. Woodruff,et al.  The Navigation Guide—Evidence-Based Medicine Meets Environmental Health: Systematic Review of Human Evidence for PFOA Effects on Fetal Growth , 2014, Environmental health perspectives.

[8]  Division on Earth Review of Epa's Integrated Risk Information System (Iris) Process , 2014 .

[9]  Paula I. Johnson,et al.  The Navigation Guide—Evidence-Based Medicine Meets Environmental Health: Systematic Review of Nonhuman Evidence for PFOA Effects on Fetal Growth , 2014, Environmental health perspectives.

[10]  Paula I. Johnson,et al.  The Navigation Guide—Evidence-Based Medicine Meets Environmental Health: Integration of Animal and Human Evidence for PFOA Effects on Fetal Growth , 2014, Environmental health perspectives.

[11]  John R. Bucher,et al.  Systematic Review and Evidence Integration for Literature-Based Environmental Health Science Assessments , 2014, Environmental health perspectives.

[12]  Oladele A Ogunseitan,et al.  Dempster‐Shafer theory applied to regulatory decision process for selecting safer alternatives to toxic chemicals in consumer products , 2014, Integrated environmental assessment and management.

[13]  Lisa A Bero,et al.  Why the Cochrane risk of bias tool should include funding source as a standard item. , 2013, The Cochrane database of systematic reviews.

[14]  Igor Linkov,et al.  Use of multi‐criteria decision analysis in regulatory alternatives analysis: A case study of lead free solder , 2013, Integrated environmental assessment and management.

[15]  T. Woodruff,et al.  Instruments for Assessing Risk of Bias and Other Methodological Criteria of Published Animal Studies: A Systematic Review , 2013, Environmental health perspectives.

[16]  Linda S. Birnbaum,et al.  Implementing Systematic Review at the National Toxicology Program: Status and Next Steps , 2013, Environmental health perspectives.

[17]  P. Grandjean,et al.  Late lessons from early warnings: science, precaution, innovation , 2013 .

[18]  Assuring Access to Data for Chemical Evaluations , 2012, Environmental health perspectives.

[19]  S. Lazic,et al.  A call for transparent reporting to optimize the predictive value of preclinical research , 2012, Nature.

[20]  Paul T Anastas,et al.  Barriers to the implementation of green chemistry in the United States. , 2012, Environmental science & technology.

[21]  E. Ha,et al.  Perfluorinated Compounds in Umbilical Cord Blood and Adverse Birth Outcomes , 2012, PloS one.

[22]  D. Bellinger Comparing the population neurodevelopmental burdens associated with children's exposures to environmental chemicals and other risk factors. , 2012, Neurotoxicology.

[23]  D. Howells,et al.  Improving the Efficiency of the Development of Drugs for Stroke , 2012, International journal of stroke : official journal of the International Stroke Society.

[24]  Gloria B Post,et al.  Perfluorooctanoic acid (PFOA), an emerging drinking water contaminant: a critical review of recent literature. , 2012, Environmental research.

[25]  P. Santaguida,et al.  Assessing the Risk of Bias of Individual Studies in Systematic Reviews of Health Care Interventions , 2012 .

[26]  Sergio Sismondo,et al.  Industry sponsorship and research outcome. , 2012, The Cochrane database of systematic reviews.

[27]  T. Stahl,et al.  Toxicology of perfluorinated compounds , 2011 .

[28]  Peter L. Tsai,et al.  Global Benefits from the Phaseout of Leaded Fuel , 2011 .

[29]  M. Macleod,et al.  Preclinical studies of human disease: time to take methodological quality seriously. , 2011, Journal of molecular and cellular cardiology.

[30]  S. Fenton,et al.  Endocrine disrupting properties of perfluorooctanoic acid , 2011, The Journal of Steroid Biochemistry and Molecular Biology.

[31]  Mark J. Strynar,et al.  Polyfluorinated compounds: past, present, and future. , 2011, Environmental science & technology.

[32]  J. Giesy,et al.  Trans-placental transfer of thirteen perfluorinated compounds and relations with fetal thyroid hormones. , 2011, Environmental science & technology.

[33]  T. Fletcher,et al.  The effect of prenatal perfluorinated chemicals exposures on pediatric atopy. , 2011, Environmental research.

[34]  Jody A. Roberts,et al.  Why the toxic substances control act needs an overhaul, and how to strengthen oversight of chemicals in the interim. , 2011, Health affairs.

[35]  J. Dowd,et al.  Discovering how environmental exposures alter genes could lead to new treatments for chronic illnesses. , 2011, Health affairs.

[36]  L. Trasande,et al.  Reducing the staggering costs of environmental disease in children, estimated at $76.6 billion in 2008. , 2011, Health affairs.

[37]  Patrice Sutton,et al.  An evidence-based medicine methodology to bridge the gap between clinical and environmental health sciences. , 2011, Health affairs.

[38]  Howard Balshem,et al.  GRADE guidelines: 3. Rating the quality of evidence. , 2011, Journal of clinical epidemiology.

[39]  G. Guyatt,et al.  GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. , 2011, Journal of clinical epidemiology.

[40]  Joel Lexchin,et al.  Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments. , 2011, JAMA.

[41]  M. Macleod,et al.  Treatment of intracerebral hemorrhage in animal models: Meta‐analysis , 2011, Annals of neurology.

[42]  P. Schlattmann,et al.  Systematic survey of the design, statistical analysis, and reporting of studies published in the 2008 volume of the Journal of Cerebral Blood Flow and Metabolism , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[43]  J. Higgins Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration , 2011 .

[44]  K. Kannan,et al.  Distribution of perfluorochemicals between sera and milk from the same mothers and implications for prenatal and postnatal exposures. , 2011, Environmental pollution.

[45]  B. Koletzko,et al.  Pre- and postnatal exposure to perfluorinated compounds (PFCs). , 2010, Environmental science & technology.

[46]  M. Macleod,et al.  Improving the translational hit of experimental treatments in multiple sclerosis , 2010, Multiple sclerosis.

[47]  Michele Tarsilla Cochrane Handbook for Systematic Reviews of Interventions , 2010, Journal of MultiDisciplinary Evaluation.

[48]  David W Howells,et al.  Factors Affecting the Apparent Efficacy and Safety of Tissue Plasminogen Activator in Thrombotic Occlusion Models of Stroke: Systematic Review and Meta-Analysis , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[49]  Carlijn R Hooijmans,et al.  Enhancing search efficiency by means of a search filter for finding all studies on animal experimentation in PubMed , 2010, Laboratory animals.

[50]  Jonathan I Levy,et al.  Science and Decisions: Advancing Risk Assessment , 2010, Risk analysis : an official publication of the Society for Risk Analysis.

[51]  Samuel Y. Sessions The Convergence of Science and Governance: Research, Health Policy, and American States , 2010 .

[52]  Drummond Rennie,et al.  Integrity in scientific publishing. , 2010, Health services research.

[53]  D. Savitz,et al.  Epidemiologic Evidence on the Health Effects of Perfluorooctanoic Acid (PFOA) , 2010, Environmental health perspectives.

[54]  F. Valet,et al.  Relationship between Sponsorship and Failure Rate of Dental Implants: A Systematic Approach , 2010, PloS one.

[55]  Anna Beronius,et al.  Risk to all or none? A comparative analysis of controversies in the health risk assessment of Bisphenol A. , 2010, Reproductive toxicology.

[56]  T. Woodruff,et al.  Environmental impacts on reproductive health and fertility , 2010 .

[57]  D. Fox The Convergence of Science and Governance: Research, Health Policy, and American States , 2010 .

[58]  D. Fox,et al.  The Convergence of Science and Governance , 2010 .

[59]  L. Giudice,et al.  Comprar Environmental Impacts on Reproductive Health and Fertility | Tracey J. Woodruff | 9780521519526 | Cambridge University Press , 2010 .

[60]  J. Heindel,et al.  Environmental Impacts on Reproductive Health and Fertility: Developmental exposures and implications for early and latent disease , 2010 .

[61]  Christopher J. Portier,et al.  IARC MONOGRAPHS ON THE EVALUATION OF CARCINOGENIC RISKS TO HUMANS PReAMBLe , 2011 .

[62]  P. Glasziou,et al.  Avoidable waste in the production and reporting of research evidence , 2009, The Lancet.

[63]  G. Olsen,et al.  Perfluoroalkyl chemicals and human fetal development: an epidemiologic review with clinical and toxicological perspectives. , 2009, Reproductive toxicology.

[64]  Steven G. Gilbert,et al.  Doubt Is Their Product: How Industry’s Assault on Science Threatens Your Health , 2009, Environmental Health Perspectives.

[65]  R. Luebke,et al.  Immunotoxicity of Perfluorooctanoic Acid and Perfluorooctane Sulfonate and the Role of Peroxisome Proliferator-Activated Receptor Alpha , 2009, Critical reviews in toxicology.

[66]  R. Luebke,et al.  Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha. , 2009, Critical reviews in toxicology.

[67]  D. Rennie,et al.  Assessing authority. , 2009, JAMA.

[68]  U. Dirnagl,et al.  Evidence for the Efficacy of NXY-059 in Experimental Focal Cerebral Ischaemia Is Confounded by Study Quality , 2008, Stroke.

[69]  D. Altman,et al.  Chapter 8: Assessing risk of bias in included studies , 2008 .

[70]  G. Guyatt,et al.  Going from evidence to recommendations , 2008, BMJ : British Medical Journal.

[71]  B. McNeil,et al.  Knowing What Works in Health Care: A Roadmap for the Nation , 2008 .

[72]  G. Guyatt,et al.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations , 2008, BMJ : British Medical Journal.

[73]  A. A. Jensen,et al.  Emerging endocrine disrupters: perfluoroalkylated substances. , 2008, International journal of andrology.

[74]  D. Gee Establishing evidence for early action: the prevention of reproductive and developmental harm. , 2008, Basic & clinical pharmacology & toxicology.

[75]  G. Donnan,et al.  Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis. , 2007, Brain : a journal of neurology.

[76]  M. Glass,et al.  Meta‐analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences , 2007, British journal of pharmacology.

[77]  C. Lau,et al.  Perfluoroalkyl acids: a review of monitoring and toxicological findings. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[78]  Lisa Bero,et al.  Factors Associated with Findings of Published Trials of Drug–Drug Comparisons: Why Some Statins Appear More Efficacious than Others , 2007, PLoS medicine.

[79]  Andrew Nugent,et al.  Emergency medicine. , 2007, Clinical privilege white paper.

[80]  Andrea Pfahles-Hutchens,et al.  The Applicability of Biomonitoring Data for Perfluorooctanesulfonate to the Environmental Public Health Continuum , 2006, Environmental health perspectives.

[81]  J. Grauer,et al.  Industry Support and Correlation to Study Outcome for Papers Published in Spine , 2005, Spine.

[82]  C. Lau,et al.  The developmental toxicity of perfluoroalkyl acids and their derivatives. , 2004, Toxicology and applied pharmacology.

[83]  Jeffrey H Mandel,et al.  Characterization of risk for general population exposure to perfluorooctanoate. , 2004, Regulatory toxicology and pharmacology : RTP.

[84]  David W Howells,et al.  Pooling of Animal Experimental Data Reveals Influence of Study Design and Publication Bias , 2004, Stroke.

[85]  Roger G Perkins,et al.  The Toxicology of Perfluorooctanoate , 2004, Critical reviews in toxicology.

[86]  Kennon Heard,et al.  Emergency medicine animal research: does use of randomization and blinding affect the results? , 2003, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[87]  B. Djulbegovic,et al.  Pharmaceutical industry sponsorship and research outcome and quality: systematic review , 2003, BMJ : British Medical Journal.

[88]  Yoichi Kawashima,et al.  Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals. , 2003, The Journal of toxicological sciences.

[89]  Pim de Voogt,et al.  Environmental and toxicity effects of perfluoroalkylated substances. , 2003, Reviews of environmental contamination and toxicology.

[90]  L. Bero,et al.  Why review articles on the health effects of passive smoking reach different conclusions. , 1998, JAMA.

[91]  L. Bero,et al.  Scientific quality of original research articles on environmental tobacco smoke , 1997, Tobacco Control.

[92]  D. Sliney Ultraviolet radiation exposure dosimetry of the eye : a report to the World Health Organization and United Nations Environment Programme , 1995 .

[93]  F. Mosteller,et al.  A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. , 1992, JAMA.

[94]  Batavia Mk,et al.  Clean Air Act Amendments of 1990. , 1991 .

[95]  金錫俊 1990 , 1990, Literatur in der SBZ/DDR.

[96]  A. B. Hill The Environment and Disease: Association or Causation? , 1965, Proceedings of the Royal Society of Medicine.